Skip to main content
William Smith

William Smith

Senior Fellow and Director of Life Sciences Initiative at Pioneer Institute; healthcare policy expert focused on biopharmaceutical regulation and the 340B drug pricing program.

Jun 25, 2026

3:14
Why were you approached to do this study? What was the methodology and what were you asked to do?
3:18
Well, the study was instigated by Cancer Care, which is a patient advocacy organization for cancer patients.
3:24
And they had been getting anecdotal reports from their patients that they went into 340B hospitals and they couldn't get charity care or that the hospital wouldn't accept Medicaid.
3:35
And that's kind of a violation of the spirit of this statute.
3:38
The whole point of this statute was to give more resources to these safety net hospitals and clinics so that they could treat more low-income patients.
3:48
We got anecdotal reports that this wasn't happening.
3:52
And so we decided, let's do a study.
5:16
Does this imply then that the charity hospitals that are being covered and getting tax breaks are actually providing less uninsured care, which is sort of the whole point of the program?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.